New Zealand markets closed

Takeda Pharmaceutical Company Limited (TAK)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
14.22+0.40 (+2.89%)
At close: 04:00PM EDT
14.33 +0.11 (+0.77%)
After hours: 06:46PM EDT
Annual

Cash flow

Currency in JPY. All numbers in thousands
Breakdown
ttm
31/03/2022
31/03/2021
31/03/2020
31/03/2019
Cash flows from operating activities
Net income
197,389,000
230,059,000
376,005,000
44,241,000
109,126,000
Depreciation & amortisation
598,486,000
583,151,000
559,671,000
583,649,000
272,446,000
Deferred income taxes
37,605,000
72,405,000
-9,936,000
-105,044,000
-14,118,000
Stock-based compensation
47,119,000
43,374,000
37,663,000
29,122,000
20,084,000
Change in working capital
71,036,000
98,605,000
275,781,000
94,672,000
75,946,000
Inventory
-34,257,000
-46,148,000
25,978,000
137,492,000
58,678,000
Other working capital
798,367,000
937,068,000
774,463,000
452,042,000
194,365,000
Other non-cash items
147,291,000
184,314,000
120,717,000
141,308,000
-12,867,000
Net cash provided by operating activities
1,040,488,000
1,123,105,000
1,010,931,000
669,752,000
328,479,000
Cash flows from investing activities
Investments in property, plant and equipment
-242,121,000
-186,037,000
-236,468,000
-217,710,000
-134,114,000
Acquisitions, net
-22,123,000
-49,672,000
0
-4,890,000
-2,958,686,000
Purchases of investments
-8,023,000
-8,341,000
-12,596,000
-7,551,000
-17,099,000
Sales/maturities of investments
22,616,000
16,921,000
74,604,000
49,402,000
65,035,000
Other investing activities
-7,011,000
-7,327,000
-10,343,000
-14,125,000
64,274,000
Net cash used for investing activities
-222,394,000
-198,125,000
393,530,000
292,119,000
-2,835,698,000
Cash flows from financing activities
Debt repayment
-633,693,000
-849,811,000
-1,690,976,000
-731,057,000
-1,741,000
Common stock repurchased
-101,918,000
-77,531,000
-2,141,000
-3,737,000
-1,172,000
Dividends paid
-280,506,000
-283,665,000
-283,357,000
-282,582,000
-142,952,000
Other financing activities
-
-385,000
-35,002,000
-5,593,000
-36,229,000
Net cash used provided by (used for) financing activities
-874,945,000
-1,070,265,000
-1,088,354,000
-1,005,213,000
2,946,237,000
Net change in cash
-56,850,000
-145,285,000
316,107,000
-43,342,000
439,018,000
Cash at beginning of period
654,920,000
966,222,000
637,614,000
702,722,000
294,973,000
Cash at end of period
598,072,000
849,695,000
966,222,000
637,614,000
702,093,000
Free cash flow
Operating cash flow
1,040,488,000
1,123,105,000
1,010,931,000
669,752,000
328,479,000
Capital expenditure
-242,121,000
-186,037,000
-236,468,000
-217,710,000
-134,114,000
Free cash flow
798,367,000
937,068,000
774,463,000
452,042,000
194,365,000